Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-17

FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approves Accord Healthcare's supplemental application for mycophenolate mofetil. The generic product is approved for use in preventing organ transplant reje…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)